{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:55:36Z","timestamp":1769558136653,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T00:00:00Z","timestamp":1579824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011287","name":"American Academy of Clinical Toxicology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011287","id-type":"DOI","asserted-by":"crossref"}]},{"name":"HealthPartners Institute for Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s13181-020-00758-8","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T16:15:26Z","timestamp":1579882526000},"page":"212-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7714-8826","authenticated-orcid":false,"given":"Jon B","family":"Cole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin N","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin M","family":"Engebretsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel J","family":"Stellpflug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,24]]},"reference":[{"issue":"2","key":"758_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/bcpt.13231","volume":"125","author":"M Lauterbach","year":"2019","unstructured":"Lauterbach M. Clinical toxicology of beta-blocker overdose in adults. Basic Clin Pharmacol Toxicol. 2019;125(2):178\u201386.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"12","key":"758_CR2","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15563650.2018.1533727","volume":"56","author":"DD Gummin","year":"2018","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 35th annual report. Clin Toxicol. 2018 Dec;56(12):1213\u2013415.","journal-title":"Clin Toxicol"},{"issue":"4","key":"758_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/15563650.2013.770152","volume":"51","author":"JB Cole","year":"2013","unstructured":"Cole JB, Stellpflug SJ, Ellsworth H, Anderson CP, Adams AB, Engebretsen KM, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol. 2013 May;51(4):201\u20137.","journal-title":"Clin Toxicol"},{"issue":"4","key":"758_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3109\/15563659309025759","volume":"31","author":"P Taboulet","year":"1993","unstructured":"Taboulet P, Cariou A, Berdeaux A, Bismuth C. Pathophysiology and management of self-poisoning with beta-blockers. J Toxicol Clin Toxicol. 1993;31(4):531\u201351.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"10","key":"758_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.ajem.2018.02.004","volume":"36","author":"JB Cole","year":"2018","unstructured":"Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36(10):1817\u201324.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"758_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/15563650500394795","volume":"44","author":"JS Holger","year":"2006","unstructured":"Holger JS, Engebretsen KM, Obetz CL, Kleven TL, Harris CR. A comparison of vasopressin and glucagon in beta-blocker induced toxicity. Clin Toxicol. 2006;44(1):45\u201351.","journal-title":"Clin Toxicol"},{"issue":"4","key":"758_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MCC.0000000000000632","volume":"25","author":"B Levy","year":"2019","unstructured":"Levy B, Buzon J, Kimmoun A. Inotropes and vasopressors use in cardiogenic shock: when, which and how much? Curr Opin Crit Care. 2019;25(4):384\u201390.","journal-title":"Curr Opin Crit Care"},{"issue":"19","key":"758_CR8","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2174\/1381612825666190704101907","volume":"25","author":"H Knotzer","year":"2019","unstructured":"Knotzer H, Poidinger B, Kleinsasser A. Pharmacologic agents for the treatment of vasodilatory shock. Curr Pharm Des. 2019;25(19):2133\u20139.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"758_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/15563650.2017.1284329","volume":"55","author":"CA Skoog","year":"2017","unstructured":"Skoog CA, Engebretsen KM. Are vasopressors useful in toxin-induced cardiogenic shock? Clin Toxicol. 2017 Apr;55(4):285\u2013304.","journal-title":"Clin Toxicol"},{"issue":"11","key":"758_CR10","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/15563650.2019.1580372","volume":"57","author":"KG Katzung","year":"2019","unstructured":"Katzung KG, Leroy JM, Boley SP, Stellpflug SJ, Holger JS, Engebretsen KM. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock. Clin Toxicol. 2019 Nov;57(11):1073\u20139.","journal-title":"Clin Toxicol"},{"issue":"4","key":"758_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/15563650701285412","volume":"45","author":"JS Holger","year":"2007","unstructured":"Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol. 2007 May;45(4):396\u2013401.","journal-title":"Clin Toxicol"},{"issue":"6","key":"758_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0196-0644(97)70196-3","volume":"29","author":"W Kerns 2nd","year":"1997","unstructured":"Kerns W 2nd, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute beta-blocker toxicity. Ann Emerg Med. 1997 Jun;29(6):748\u201357.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"758_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/096032719601500204","volume":"15","author":"AE Toet","year":"1996","unstructured":"Toet AE, te Biesebeek JD, Vleeming W, Wemer J, Meulenbelt J, de Wildt DJ. Reduced survival after isoprenaline\/dopamine in d,l-propranolol intoxicated rats. Hum Exp Toxicol. 1996 Feb;15(2):120\u20138.","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"758_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/096032719601500509","volume":"15","author":"AE Toet","year":"1996","unstructured":"Toet AE, Wemer J, Vleeming W, te Biesebeek JD, Meulenbelt J, de Wildt DJ. Experimental study of the detrimental effect of dopamine\/glucagon combination in d,l-propranolol intoxication. Hum Exp Toxicol. 1996 May;15(5):411\u201321.","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"758_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/15563659209021555","volume":"30","author":"JN Love","year":"1992","unstructured":"Love JN, Leasure JA, Mundt DJ, Janz TG. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. J Toxicol Clin Toxicol. 1992;30(3):399\u2013412.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"7","key":"758_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3109\/15563650.2011.593522","volume":"49","author":"JS Holger","year":"2011","unstructured":"Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol. 2011 Aug;49(7):653\u20138.","journal-title":"Clin Toxicol"},{"issue":"2","key":"758_CR17","first-page":"744","volume":"267","author":"JA Kline","year":"1993","unstructured":"Kline JA, Tomaszewski CA, Schroeder JD, Raymond RM. Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine. J Pharmacol Exp Ther. 1993 Nov;267(2):744\u201350.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"758_CR18","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1213\/01.ANE.0000066017.66951.7F","volume":"96","author":"KH Stadlbauer","year":"2003","unstructured":"Stadlbauer KH, Wagner-Berger HG, Wenzel V, Voelckel WG, Krismer AC, Klima G, et al. Survival with full neurologic recovery after prolonged cardiopulmonary resuscitation with a combination of vasopressin and epinephrine in pigs. Anesth Analg. 2003;96(6):1743\u20139 table of contents.","journal-title":"Anesth Analg"},{"issue":"2","key":"758_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa025431","volume":"350","author":"V Wenzel","year":"2004","unstructured":"Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med. 2004;350(2):105\u201313.","journal-title":"N Engl J Med"},{"issue":"8","key":"758_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3109\/15563650.2010.521753","volume":"48","author":"KM Engebretsen","year":"2010","unstructured":"Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP, Holger JS. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol. 2010 Oct;48(8):806\u201312.","journal-title":"Clin Toxicol"},{"key":"758_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for survey nonresponse","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for survey nonresponse. New York: Wiley; 1987."},{"issue":"4","key":"758_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0735-6757(93)90168-B","volume":"11","author":"JN Love","year":"1993","unstructured":"Love JN, Leasure JA, Mundt DJ. A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model. Am J Emerg Med. 1993;11(4):360\u20133.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"758_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/15563659409017960","volume":"32","author":"S Sato","year":"1994","unstructured":"Sato S, Tsuji MH, Okubo N, Naito H. Milrinone versus glucagon: comparative hemodynamic effects in canine propranolol poisoning. J Toxicol Clin Toxicol. 1994;32(3):277\u201389.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"4","key":"758_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/15563659509028919","volume":"33","author":"S Sato","year":"1995","unstructured":"Sato S, Tsuji MH, Okubo N, Nishimoto C, Naito H. Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model. J Toxicol Clin Toxicol. 1995;33(4):337\u201342.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"6","key":"758_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.annemergmed.2009.06.512","volume":"54","author":"H Leppikangas","year":"2009","unstructured":"Leppikangas H, Ruokonen E, Rutanen J, Kiviniemi V, Lindgren L, Kurola J. Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study. Ann Emerg Med. 2009;54(6):811\u20137.e1\u20133.","journal-title":"Ann Emerg Med"},{"issue":"6","key":"758_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1292\/jvms.68.549","volume":"68","author":"M Uechi","year":"2006","unstructured":"Uechi M, Hori Y, Fujimoto K, Ebisawa T, Yamano S, Maekawa S. Cardiovascular effects of a phosphodiesterase III inhibitor in the presence of carvedilol in dogs. J Vet Med Sci. 2006;68(6):549\u201353.","journal-title":"J Vet Med Sci"},{"issue":"9","key":"758_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1177\/0960327111433182","volume":"31","author":"Y Kalam","year":"2012","unstructured":"Kalam Y, Graudins A. Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity. Hum Exp Toxicol. 2012;31(9):955\u201363.","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"758_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1091581811435366","volume":"31","author":"Y Kalam","year":"2012","unstructured":"Kalam Y, Graudins A. Levosimendan does not improve cardiac output or blood pressure in a rodent model of propranolol toxicity when administered using various dosing regimens. Int J Toxicol. 2012;31(2):166\u201374.","journal-title":"Int J Toxicol"},{"issue":"3","key":"758_CR29","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13181-014-0382-7","volume":"10","author":"JB Cole","year":"2014","unstructured":"Cole JB, Stellpflug SJ, Engebretsen KM. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3):307\u201310.","journal-title":"J Med Toxicol"},{"key":"758_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21037\/acr.2018.04.02","volume":"2","author":"PJ Bradley","year":"2018","unstructured":"Bradley PJ. Guidelines to authors publishing a case report: the need for quality improvement. AME Case Rep. 2018;2:10.","journal-title":"AME Case Rep"},{"issue":"1","key":"758_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13181-015-0486-8","volume":"12","author":"GS Wang","year":"2016","unstructured":"Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S, et al. Extracorporeal membrane oxygenation (ECMO) for severe toxicological exposures: review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016;12(1):95\u20139.","journal-title":"J Med Toxicol."},{"issue":"3","key":"758_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s13181-019-00704-3","volume":"15","author":"J Lewis","year":"2019","unstructured":"Lewis J, Zarate M, Tran S, Albertson T. The recommendation and use of extracorporeal membrane oxygenation (ECMO) in cases reported to the California Poison Control System. J Med Toxicol. 2019;15(3):169\u201377.","journal-title":"J Med Toxicol."},{"issue":"3","key":"758_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s13181-019-00707-0","volume":"15","author":"BS Orozco","year":"2019","unstructured":"Orozco BS, Engebretsen KM, Holger JS, Stellpflug SJ. A swine model of severe propranolol toxicity permitting direct measurement of brain tissue oxygenation. J Med Toxicol. 2019;15(3):178\u201383.","journal-title":"J Med Toxicol"},{"key":"758_CR34","doi-asserted-by":"publisher","unstructured":"Camacho P, Fan H, Liu Z, He J-Q. Large mammalian animal models of heart disease. J Cardiovasc Dev Dis [Internet]. 2016;3(4). Available from:). https:\/\/doi.org\/10.3390\/jcdd3040030.","DOI":"10.3390\/jcdd3040030"},{"issue":"2","key":"758_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s13181-011-0209-8","volume":"8","author":"CA Truitt","year":"2012","unstructured":"Truitt CA, Brooks DE, Dommer P, LoVecchio F. Outcomes of unintentional beta-blocker or calcium channel blocker overdoses: a retrospective review of poison center data. J Med Toxicol. 2012 Jun;8(2):135\u20139.","journal-title":"J Med Toxicol."},{"issue":"1","key":"758_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s13181-014-0419-y","volume":"11","author":"CW Heise","year":"2015","unstructured":"Heise CW, Beutler D, Bosak A, Orme G, Loli A, Graeme K. Massive atenolol, lisinopril, and chlorthalidone overdose treated with endoscopic decontamination, hemodialysis, impella percutaneous left ventricular assist device, and ECMO. J Med Toxicol. 2015 Mar;11(1):110\u20134.","journal-title":"J Med Toxicol."},{"issue":"4","key":"758_CR37","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s13181-015-0500-1","volume":"11","author":"JR Laes","year":"2015","unstructured":"Laes JR, Williams DM, Cole JB. Improvement in hemodynamics after methylene blue administration in drug-induced vasodilatory shock: a case report. J Med Toxicol. 2015 Dec;11(4):460\u20133.","journal-title":"J Med Toxicol."},{"issue":"2","key":"758_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s13181-010-0133-3","volume":"7","author":"SJ Stellpflug","year":"2011","unstructured":"Stellpflug SJ, Fritzlar SJ, Cole JB, Engebretsen KM, Holger JS. Cardiotoxic overdose treated with intravenous fat emulsion and high-dose insulin in the setting of hypertrophic cardiomyopathy. J Med Toxicol. 2011 Jun;7(2):151\u20133.","journal-title":"J Med Toxicol."},{"issue":"3","key":"758_CR39","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1111\/j.1540-8159.2012.03485.x","volume":"36","author":"H Ellsworth","year":"2013","unstructured":"Ellsworth H, Stellpflug SJ, Cole JB, Dolan JA, Harris CR. A life-threatening flecainide overdose treated with intravenous fat emulsion. Pacing Clin Electrophysiol. 2013 Mar;36(3):e87\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"758_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13181-015-0483-y","volume":"12","author":"RE Bruccoleri","year":"2016","unstructured":"Bruccoleri RE, Burns MM. A literature review of the use of sodium bicarbonate for the treatment of QRS widening. J Med Toxicol. 2016 Mar;12(1):121\u20139.","journal-title":"J Med Toxicol."},{"issue":"12","key":"758_CR41","doi-asserted-by":"publisher","first-page":"1840.e3","DOI":"10.1016\/j.ajem.2015.04.012","volume":"33","author":"E Brumfield","year":"2015","unstructured":"Brumfield E, KRL B, Kabrhel C. Life-threatening flecainide overdose treated with intralipid and extracorporeal membrane oxygenation. Am J Emerg Med. 2015;33(12):1840.e3\u20135.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"758_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1081\/CLT-120023761","volume":"41","author":"B Bailey","year":"2003","unstructured":"Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review. J Toxicol Clin Toxicol. 2003;41(5):595\u2013602.","journal-title":"J Toxicol Clin Toxicol"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00758-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-020-00758-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00758-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T16:48:53Z","timestamp":1695660533000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-020-00758-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,24]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s13181-020-00758-8","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,24]]},"assertion":[{"value":"23 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}